| Literature DB >> 22039453 |
Inês Vitoriano1, Kathy D Saraiva-Pava, Alexandra Rocha-Gonçalves, Andrea Santos, Ana I Lopes, Mónica Oleastro, Mónica Roxo-Rosa.
Abstract
Infection with Helicobacter pylori is the major cause for the development of peptic ulcer disease (PUD). In children, with no other etiology for the disease, this rare event occurs shortly after infection. In these young patients, habits of smoking, diet, consumption of alcohol and non-steroid anti-inflammatory drugs and stress, in addition to the genetic susceptibility of the patient, represent a minor influence. Accordingly, the virulence of the implicated H. pylori strain should play a crucial role in the development of PUD. Corroborating this, our in vitro infection assays comparing a pool of five H. pylori strains isolated from children with PUD to a pool of five other pediatric clinical isolates associated with non-ulcer dyspepsia (NUD) showed the greater ability of PUD strains to induce a marked decrease in the viability of gastric cells and to cause severe damage in the cells cytoskeleton as well as an impairment in the production/secretion of mucins. To uncover virulence features, we compared the proteome of these two groups of H. pylori strains. Two-dimensional gel electrophoresis followed by mass-spectrometry allowed us to detect 27 differentially expressed proteins between them. In addition to the presence of genes encoding well established virulence factors, namely cagA, vacAs1, oipA "on" status, homB and jhp562 genes, the pediatric ulcerogenic strains shared a proteome profile characterized by changes in the abundance of: motility-associated proteins, accounting for higher motility; antioxidant proteins, which may confer increased resistance to inflammation; and enzymes involved in key steps in the metabolism of glucose, amino acids and urea, which may be advantageous to face fluctuations of nutrients. In conclusion, the enhanced virulence of the pediatric ulcerogenic H. pylori strains may result from a synergy between their natural ability to better adapt to the hostile human stomach and the expression of the established virulence factors.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22039453 PMCID: PMC3198394 DOI: 10.1371/journal.pone.0026265
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characterization of the H. pylori strains included in the study and of the patients from whom each of them was isolated.
|
| Patient | |||||||
| Strain |
|
|
|
|
| Histologic Analysis | Age | Gender |
|
| − | s2 | off | − | − | NUD | 14 | M |
|
| − | s2 | off | − | − | NUD | 7 | F |
|
| − | s2 | off | − | − | NUD | 8 | M |
|
| − | s2 | off | − | − | NUD | 11 | M |
|
| − | s2 | off | − | − | NUD | 11 | M |
|
| + | s1 | on | + | + | GU | 11 | M |
|
| + | s1 | on | + | + | DU | 10 | M |
|
| + | s1 | on | + | + | DU | 10 | M |
|
| + | s1 | on | + | + | DU | 15 | M |
|
| + | s1 | on | + | − | DU | 13 | M |
All strains are indicated by their collection number. All patients were from Portugal. In columns cagA, homB and jhp562: + indicates strain containing the gene; − indicates strain lacking the gene. vacA column: s1 indicates strains containing the toxic allele of the gene; and s2, strain containing the non-toxic allele of the gene. oipA column: on indicates strains containing the functional allele of the gene; and off, strains containing the non-functional allele of the gene. NUD - non-ulcer dyspepsia; DU – duodenal ulcer; GU – gastric ulcer. M - Masculine; F - Feminine.
Figure 1Impact of the two isogenic groups of pediatric H. pylori strains on NCI-N87 cells viability.
The viability of NCI-N87 cells was assessed by the trypan blue exclusion assay after 1, 12 and 24 h of co-culture with a pool of five pediatric PUD-associated strains (▪ in full line) and a pool of five pediatric NUD-associated strains (• in dashed line). For normalization, the value of 100% corresponds to the viability of non-infected NCI-N87 cells. * indicates values that were determined as significantly different (p<0.05) between the viability of cells infected with PUD strains and that of cells infected with NUD-strains at the same time-point of co-culture. Symbols and error bars are means ± SD of the values at each point for 3 observations.
Figure 2Impact of the two isogenic groups of pediatric H. pylori strains on the NCI-N87 cells morphology.
NCI-N87 cells grown to 80–90% confluence were co-cultured for 24 h with the pool of five isogenic NUD-associated H. pylori strains (NUD) and in parallel with the pool of five isogenic PUD strains (PUD). The control corresponds to non-infected NCI-N87 cells. A), B), and C) light microscopy observations. D), E), and F) immunodetection of the microtubule network (green) (1∶1000 α-tubulin antibody plus a FITC conjugated secondary antibody). G), H), and I) PAS staining alone, and in J), L), and M) in conjugation with hematoxylin. Dark arrow indicates extracellular vesicles that reacted with PAS.
Figure 3Profile of the soluble proteome of the 10 studied pediatric H. pylori strains.
These include five strains associated with NUD (173/00, 207/99, 228/99, 655/99 and 1786/05), four from patients affected by DU (1089/03, 1152/04, 1198/04 and 1846/05) and a strain associated with GU (499/02). Proteins from the total biomass recovered from a 24 h grown plate were separated by 2DE, i.e., first in a non-linear pH 3–11 and than in a 7–16% (w/v) SDS-PAGE. After CBB-staining, gels were analyzed using ImageMaster™ 2-D Platinum software. Black arrow indicates spots that were more abundant in PUD (DU+GU) strains when compared to NUD strains; Dotted arrow indicates spots that were less abundant in PUD (DU+GU) strains when compared to NUD strains; Dashed arrow indicates the spot that was shifted right in DU strains when compared to NUD strains. Spot numbers indicated in the 2DE maps are the same as used in Table 2.
Identification of proteins found to be differentially expressed in H. pylori strains from PUD patients (n = 5) compared to NUD patients (n = 5).
| Theoretical | % Vol | |||||||||||||||
| Spot no. | Protein | Cellular function | ORF | Swiss-Prot/NCBI no. | Mw (kDa) | pI | MOWSE score | Peptides matched | Sequence coverage (%) | Average NUD ± S.D | Average DU ± S.D | Variation (DU/NUD) |
| Variation (GU/DU) | ||
| 1 | CagA, Cytotoxin associated protein A | Induces abnormal proliferation; tight junctions disruption; cytoskeleton rearrangements | HP0547 | gi|307135439 | 131 | 8.9 | 82 | * | 10/16 | 7 | absent | 1.558±0.487 |
| 5.265E-08 | * |
|
| 2 | FlgE, Flagellar hook protein | Component of bacteria flagellum basal body | HP0870 | Q9ZKY0 | 76 | 5.0 | 71 | * | 12/35 | 17 | 0.077±0.036 | 0.136±0.055 |
| 2.099E-02 | * |
|
| 3 | FlaA, Flagellin A | Major component of bacteria flagellum | HP0601 | P0A0S2 | 53 | 6.0 | 121 | * | 14/37 | 14 | 2.130±0.794 | 3.063±0.941 |
| 4.706E-02 | * |
|
| 4 | HspB, Chaperone and heat shock protein | Protein folding/stress response | HP0010 | B6JPA7 | 58 | 5.4 | 93 | * | 18/55 | 26 | 5.021±0.556 | 5.856±0.533 |
| 7.801E-03 | * |
|
| 5 | UreB, Urease beta subunit | Urea metabolism | P14917 | P69996 | 62 | 5.6 | Comparison to 2DE database | 8.815±1.310 | 10.477±1.455 |
| 3.551E-02 | * |
| |||
| 6 | HyuA, Hydantoin utilization protein A | Arginine and proline metabolism | HP0695 | gi|108563105 | 79 | 6.4 | 105 | * | 24/100 | 20 | 0.503±0.128 | 0.204±0.110 |
| 4.079E-04 | * |
|
| 7 | Unknown | — | — | — | — | — | — | 1.094±0.702 | absent |
| 2.706E-04 | * |
| |||
| 8 | RpsA, 30S Ribosomal protein s1 | Translation process | HP0399 | P56008 | 63 | 6.3 | Comparison to 2DE database | 0.126±0.029 | 0.085±0.022 |
| 1.141E-02 | * |
| |||
| 9 | KatA, Catalase | Detoxification | HP0875 | P77872 | 59 | 8.7 | 161 | * | 21/48 | 37 | 4.833±0.962 | 2.669±0.621 |
| 1.292E-04 | * |
|
| 10 | CysS, Cysteinyl-tRNA synthetase | Translation process | HP0886 | B5Z7P5 | 53 | 6.0 | 28 | 4/23 | 8 | 0.152±0.091 | 0.027±0.024 |
| 2.615E-03 | * |
| |
| 11 | AspA, Aspartate ammonia-lyase | Catalyzes the deamination of aspartate originating fumarate | HP0649 | gi|207108618 | 35 | 8.5 | 58 | 5/23 | 10 | 0.396±0.097 | 0.252±0.089 |
| 9.261E-03 | * |
| |
| 12 | Pgk, Phosphoglycerate kinase | Glucose metabolism | HP1345 | gi|261838924 | 44 | 6.3 | 86 | * | 10/33 | 27 | 0.213±0.064 | 0.303±0.069 |
| 2.525E-02 | * |
|
| 13 | HPAG1_1081, Hypothetical protein | Putative function in cell shape | HP1143 | gi|108563506 | 51 | 5.5 | 77 | * | 11/23 | 15 | absent | 0.200±0.072 |
| 3.577E-07 | * | absent |
| 14 | EF-Ts, Elongation factor Ts | Translation process | HP1555 | B6JP47 | 40 | 6.2 | 76 | * | 7/13 | 16 | 0.606±0.101 | 0.613±0.185 |
| 9.206E-01 | normal position | |
| 15 | Putative aldo-keto reductase | Catalyze the reduction of aldehydes and ketones to the corresponding alcohol product | HP1193 | gi|254779741 | 37 | 6.7 | 86 | * | 8/18 | 22 | 0.015±0.040 | 0.147±0.224 |
| 7.418E-03 | * |
|
| 16 | HELPY_0944, Hypothetical protein | Motility | HP0958 | gi|254779556 | 30 | 5.6 | 99 | * | 13/46 | 41 | 0.231±0.080 | 0.165±0.026 |
| 8.453E-02 |
| |
| 17 | HP_1588, UPF0174 protein | Unknown | HP1588 | O26107 | 29 | 5.5 | 85 | * | 8/17 | 15 | 0.322±0.123 | 0.563±0.373 |
| 2.293E-03 | * |
|
| 18 | HP_1588, UPF0174 protein | Unknown | HP1588 | O26107 | 29 | 5.5 | 90 | * | 10/30 | 28 | 0.853±0.192 | 0.399±0.167 |
| 5.076E-04 | * |
|
| 19 | ScoA, Succinyl-CoA-transferase subunit A | Citric acid cycle | HP0691 | P56006 | 26 | 5.8 | 41 | 3/7 | 11 | 0.199±0.051 | 0.052±0.053 |
| 3.739E-05 | * |
| |
| 20 | UreA, Urease subunit alpha | Urea metabolism | HP0073 | Q9ZMZ4 | 27 | 8.5 | 145 | * | 12/26 | 43 | 0.798±0.078 | 1.082±0.214 |
| 3.314E-03 | * |
|
| 21 | ScoB, Succinyl-CoA-transferase subunit B | Citric acid cycle | HP0692 | gi|208434607 | 22 | 5.4 | 104 | * | 10/33 | 33 | 0.242±0.066 | 0.149±0.061 |
| 1.070E-02 | * |
|
| 22 | AroQ, 3-dehydroquinate dehydratase | Aromatic aminoacid biosynthesis | HP1038 | B6JKY5 | 19 | 5.1 | 77 | * | 8/36 | 35 | 0.520±0.108 | 0.622±0.077 |
| 5.503E-02 |
| |
| 23 | Pfr, Ferritin | Iron storage protein | HP0653 | Q9ZLI1 | 19 | 5.4 | 40 | 4/23 | 23 | 0.728±0.295 | 1.185±0.193 |
| 4.285E-03 | * |
| |
| 24 | Porγ, Pyruvate flavodoxin oxidoreductase, gamma subunit | Decarboxylation of pyruvate in acetyl-CoA | HP1108 | gi|15645722 | 21 | 8.5 | 88 | * | 10/33 | 36 | 0.313±0.086 | 0.141±0.033 |
| 1.133E-04 | * |
|
| 25 | FldA, Flavodoxin | Electron transport process | HP1161 | O25776 | 17 | 4.5 | 73 | * | 5/14 | 42 | 0.657±0.277 | 1.259±0.430 |
| 6.800E-03 | * |
|
| 26 | NapA, Neutrophil activating protein A | Protects DNA from oxidative damage; activates neutrophils, mast cells and monocytes | HP0243 | gi|7188724 | 17 | 5.7 | 103 | * | 16/100 | 79 | 1.350±0.567 | 1.933±0.360 |
| 2.996E-02 | * |
|
| 27 | HPG27_1480 | Putative function in cell shape | HP1542 | gi|208435422 | 11 | 5.6 | 48 | 3/13 | 35 | 0.065±0.016 | 0.088±0.007 |
| 4.953E-03 | * |
| |
“Comparison to 2DE databases” indicates spots for which identification was done by finding the corresponding spot on the standard H. pylori 2DE gel from the database [14]. All of the others were identified by PMF analysis. For each spot the average of the % Vol ± S.D. is indicated. In the Variation (DU/NUD) column: ↑, proteins for which the average of the % Vol of spots on DU 2DE maps was higher than that on NUD 2DE maps; ↓, proteins for which the average of the % Vol of spots on DU 2DE maps was lower than that on NUD 2DE maps; ↔, proteins that were shifted right in the DU 2DE-maps regarding their position on the NUD 2DE-maps. In the Variation (GU/NUD) column: ↑, proteins for which the average of the % Vol of spots on GU 2-DE maps was higher than that on the DU 2DE maps; ↓, proteins for which the average of the % Vol of spots on GU 2DE maps was lower than that on DU 2DE maps; = , proteins showing the same pattern of expression observed for the H. pylori strains associated with DU. Asterisks indicate statistical significant results (p<0.05). 1Indicates the identified ORF in the 26695 reference strain.
Figure 4Motility of the two isogenic groups of pediatric H. pylori strains in study.
The five strains of each class, recovered from 24 h grown plates, were pooled together, inoculated on semi-solid BHI broth −5% FBS medium plates and incubated for 11 days at 37°C under microaerophilic conditions. A) The growth halo observed at day 5 for the pool of PUD and of NUD strains. B) Variation of the diameter of the growth halo along the time (▪ in full line refers to PUD strains and • in dashed line refers to NUD strains). Symbols are means of the values at each point for 2 observations.
Figure 5Schematic diagram of the DU development in children upon H. pylori infection.
The virulence of the pediatric PUD-associated H. pylori strains results from a synergy between their natural ability to better adapt to the hostile human stomach and their virulence factors. Adaptation is ensured by: higher motility (↑ FlaA, ↑ FlgE, ↓ HELP_0944, ↑ HPAG1_1081, and ↑ HPG27_1480), higher ability to survive under low pH conditions (↑ UreA and B and ↑ putative aldo-keto reductase), better antioxidant defenses against inflammation (↑ Pfr, ↑ NapA and ↓ KatA), modified metabolism (↓ HyuA, ↓ AspA, ↑ Pgk, ↓ ScoA and B, ↑AroQ, ↓ Porγ, ↑ FldA, ↓ RpsA and ↓ CysS), adhesion (indicated by a anchor) mediated by “on” OipA and HomB. Virulence factors (indicated by a bomb): cagA and VacAs1. 1 – Infection; 2 – Host response (acid hypersecretion and inflammation); 3 – duodenal acid injury (Duodenal Ulcer, indicated by an explosion symbol). Dotted arrow - Time line.